The role of GLP-1R in AD is reflected mainly in the following aspects: it can decrease Aβ deposition and inhibit tau protein hyperphosphorylation, reduce neuroinflammation and oxidative stress (OS) (Du et al., 2022). Here, MAPT is linked to Alzheimer disease.